[HTML][HTML] Association of active immunotherapy with outcomes in cancer patients with COVID-19: a systematic review and meta-analysis

C Cao, X Gan, X Hu, Y Su, Y Zhang, X Peng - Aging (Albany NY), 2022 - ncbi.nlm.nih.gov
… The present study has strengths, including comprehensive inclusion and a multivariate
analysis. The figure for studies regarding immunotherapy included in this meta-analysis

COVID-19: immunology, immunopathogenesis and potential therapies

A Bhardwaj, L Sapra, C Saini, Z Azam… - International reviews …, 2022 - Taylor & Francis
… Knowledge of immunopathogenesis of COVID-19 will … review, we have discussed the
pathogenesis and immunopathogenesis of COVID-19 along with the potential immunotherapeutic

A nasopharyngeal carcinoma patient with COVID-19 infection after immunotherapy: a case report and literature review

M Zhai, S Zhang - in vivo, 2020 - iv.iiarjournals.org
Coronavirus Disease 2019 (COVID-19). Unfortunately, despite aggressive treatment after
the diagnosis of COVID-19, … developed severe COVID-19 after receiving immunotherapy. For …

Mechanisms and effectiveness of immunotherapy in patients infected with COVID-19

AB Carrilho, PB Carrilho… - Revista Eletrônica Acervo …, 2021 - acervomais.com.br
… la inmunoterapia en pacientes infectados por COVID19. Revisión bibliográfica: La inflamación
por citocinas está directamente asociada con el desarrollo de COVID-19 y su gravedad, …

Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine

M Shirzad, M Nourigorji, A Sajedi, M Ranjbar… - International …, 2022 - Elsevier
COVID-19. Based on these findings, this paper aims to review the different strategies of
treatment against COVID-19 … a summary from traditional and newer methods in curing COVID-19. …

The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control

YA Helmy, M Fawzy, A Elaswad, A Sobieh… - Journal of clinical …, 2020 - mdpi.com
… Therefore, the WHO has declared COVID-19 a pandemic. The disease is characterized by …
, in this review, we provide recent information about the COVID-19 pandemic. This review also …

Early experience with convalescent plasma as immunotherapy for COVID19 in China: Knowns and unknowns

B Chen, R Xia - Vox sanguinis, 2020 - Wiley Online Library
… of COVID-19. This article discusses the application of convalescent plasma as an
immunotherapy in the treatment of emerging infectious diseases, focusing on the recent COVID-19

The role of immunotherapy or immuno-chemotherapy in non-small cell lung cancer: a comprehensive review

S Mohamed, L Bertolaccini, D Galetta, F Petrella… - Cancers, 2023 - mdpi.com
Pembrolizumab or placebo for one year [44]. Preliminary results showed an improved DFS of
53.6 months in the Pembrolizumab … Moreover, the COVID-19 pandemic has also resulted in …

Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics

N Ebrahimi, S Aslani, F Babaie… - International …, 2020 - Elsevier
COVID-19 and many people die every day throughout the world. Having a deep comprehensive
… and current and potential immunotherapeutic approaches in the treatment of COVID-19. …

Harnessing immunological targets for COVID-19 immunotherapy

AK Mehata, MK Viswanadh, V Priya, Vikas… - Future …, 2021 - Taylor & Francis
… Here, we reviewed the role of innate immunity in the successful … immunotherapy for
COVID-19 infection could be new hope for humans in the battle of this deadly new coronavirus. …